|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-7-20
|
|
pubmed:abstractText |
Familial combined hyperlipidemia (FCHL) is characterized by a varied expression of hypertriglyceridemia and hypercholesterolemia within a family, and a high risk of premature coronary artery disease. The present study evaluated a number of potential prothrombotic markers in familial combined hyperlipidemia, and studied their relationship to the hypercholesterolemic (Fredrickson type IIa) and hypertriglyceridemic (IIb and IV) phenotypes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0021-9150
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2004 Elsevier Ireland Ltd
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
175
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
345-51
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15262191-Adult,
pubmed-meshheading:15262191-Antithrombin III,
pubmed-meshheading:15262191-Blood Coagulation Factors,
pubmed-meshheading:15262191-Case-Control Studies,
pubmed-meshheading:15262191-Cross-Sectional Studies,
pubmed-meshheading:15262191-Female,
pubmed-meshheading:15262191-Fibrin Fibrinogen Degradation Products,
pubmed-meshheading:15262191-Humans,
pubmed-meshheading:15262191-Hyperlipidemia, Familial Combined,
pubmed-meshheading:15262191-Lipoproteins,
pubmed-meshheading:15262191-Male,
pubmed-meshheading:15262191-Middle Aged,
pubmed-meshheading:15262191-Peptide Hydrolases,
pubmed-meshheading:15262191-Thrombomodulin,
pubmed-meshheading:15262191-Triglycerides
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Prothrombotic markers in familial combined hyperlipidemia: evidence of endothelial cell activation and relation to metabolic syndrome.
|
|
pubmed:affiliation |
Department of Internal Medicine, Cardiovascular Research Institute Maastricht, Academic Hospital Maastricht and University of Maastricht, AZ Maastricht, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
